Now screening sits at the center of this dementia and brain health question.

Doctors are increasingly screening for chronic infections as part of dementia prevention because recent research reveals a significant connection: people with severe infections requiring hospital treatment face a 1.5 to 2.6-fold increased risk of developing dementia, with higher risks observed in shorter follow-up periods. This shift represents a fundamental change in how the medical community approaches cognitive decline prevention.

Rather than treating dementia as an isolated neurological condition, researchers now recognize that systemic infections—ranging from urinary tract infections to herpes simplex virus to hepatitis C—may actively damage the brain and accelerate cognitive decline. A 72-year-old patient recovering from pneumonia, for example, might not simply regain their lung function; they may also have set themselves up for later cognitive problems if that infection triggered inflammatory cascades in the brain. This article explores why this screening approach is gaining momentum, examines the specific infections doctors now monitor, explains the biological mechanisms at work, and discusses what the evidence does and doesn’t tell us about prevention.

Which Infections Are Linked to Dementia Risk, and What Do the Numbers Tell Us?
How Do Chronic Infections Affect the Brain and Lead to Cognitive Decline?
Which Specific Pathogens Warrant Attention, and What Do We Know About Each?
The UTI-Dementia Connection: A Practical Example of Why Doctors Screen
The Evidence Gap: What We Don’t Yet Know About Prevention
Why Is the Medical Community Shifting Its Approach Now?
What’s Next? The Future of Infection Screening in Dementia Prevention
Conclusion

Which Infections Are Linked to Dementia Risk, and What Do the Numbers Tell Us?

The list of pathogens connected to dementia risk is surprisingly extensive. Hospital-treated infectious diseases—including H. pylori, herpes simplex virus type 1 (HSV-1), varicella-zoster virus (VZV), human papillomavirus (HPV), sepsis, pneumonia, osteomyelitis, urinary tract infections, cellulitis, hepatitis C, and HIV—have all been associated with increased dementia risk. The National Institutes of Health’s intramural investigators further documented that influenza, viral infections, respiratory infections, and skin infections carried long-term dementia risk. The magnitude of these associations matters: a person hospitalized with a severe infection isn’t facing a marginal uptick in risk; they’re looking at an elevated hazard that compounds over years.

To put this in perspective, the 2024 Lancet Standing Commission identified infections as one of 14 modifiable risk factors that account for approximately 45% of global dementia cases—a finding that elevates infectious disease from a peripheral concern to a central component of dementia prevention strategy. In some regions, including parts of the developing world where HIV prevalence is high, infections may account for an even larger share of preventable dementia risk, potentially pushing that figure toward 65%. The distinction between different types of infections matters for clinical practice. Respiratory infections like pneumonia carry documented dementia associations, as do recurrent urinary tract infections, which affect a substantial portion of the older population. Viral infections—particularly herpes family viruses—appear to pose particular concern. However, it’s important to note that the presence of a statistical association doesn’t automatically mean screening and treating every infection will prevent dementia; the research documents a link, but the causal pathway and the effectiveness of intervention remain active areas of investigation.

Which Infections Are Linked to Dementia Risk, and What Do the Numbers Tell Us?

How Do Chronic Infections Affect the Brain and Lead to Cognitive Decline?

Scientists have proposed two main mechanisms by which infections damage brain tissue and cognitive function. The first is the inflammation theory: chronic infections trigger a persistent inflammatory response in the brain, which exacerbates amyloid-beta (Aβ) and tau pathology—the hallmark protein accumulations seen in Alzheimer’s disease. Think of it this way: the brain’s immune system launches a response to infection, but that immune response can backfire, damaging neurons and accelerating the misfolding and accumulation of disease-associated proteins. The second mechanism is the infectious burden hypothesis, which proposes that it’s not any single infection that matters most, but rather the total accumulation of infectious challenges across a person’s lifetime. Someone who has survived H.

pylori infection, recurrent respiratory infections, and a severe urinary tract infection may carry a higher total “burden” of past infections, and that cumulative insult—not just one dramatic infection—drives cognitive risk. These mechanisms help explain why the timing and severity of infection appear to matter. Infections requiring hospitalization carry higher dementia associations than milder, outpatient infections, suggesting that severity and systemic impact play a role. However, a critical caveat applies here: the presence of a plausible biological mechanism doesn’t guarantee that intervention will work. We can understand how infections damage the brain and still not be certain that aggressively screening for and treating every chronic infection will change someone’s dementia trajectory. The inflammation theory is compelling, but it remains a theory rather than a proven causal pathway, and clinical trials testing whether infection screening prevents dementia are still limited.

Which Specific Pathogens Warrant Attention, and What Do We Know About Each?

H. pylori, the bacterium responsible for most gastric ulcers, has been epidemiologically linked to dementia risk, likely through chronic systemic inflammation and effects on nutrient absorption. Herpes simplex virus type 1 (HSV-1), which establishes lifelong latency in nerve tissues, may pose particular risk because of its ability to directly access the nervous system and trigger recurrent neuroinflammation. Varicella-zoster virus (VZV), the cause of chickenpox and shingles, similarly establishes latency and can reactivate, with some research suggesting shingles may itself carry dementia risk. Hepatitis C and HIV both cause chronic systemic infections and are well-documented in the dementia literature, particularly in populations with long-standing, untreated disease. Sepsis—overwhelming systemic infection—represents perhaps the most dramatic acute infectious insult and carries strong associations with cognitive decline, both in the immediate post-hospitalization period and in long-term follow-up.

What’s less clear is whether screening and treating asymptomatic carriers of these organisms prevents dementia. For example, many adults are H. pylori-positive and never develop dementia. Many carry HSV-1 seropositivity with no cognitive problems. This is where the distinction between association and causation becomes crucial. A person may have had H. pylori in the past, recovered from treatment, and never face dementia—suggesting that even infections with documented statistical associations may not inevitably lead to cognitive decline in all individuals.

Which Specific Pathogens Warrant Attention, and What Do We Know About Each?

The UTI-Dementia Connection: A Practical Example of Why Doctors Screen

Urinary tract infections offer perhaps the clearest real-world example of how infection screening is changing dementia care. Emergency department data reveals that up to 50% of people with dementia visit the ED annually (compared to 30% without dementia), and UTI is their most frequent discharge diagnosis. This isn’t coincidental; it reflects both the biological reality that people with existing cognitive impairment may neglect bladder health and the clinical reality that UTIs cause acute confusion in older adults. Here’s the critical distinction: UTIs cause delirium—reversible acute confusion—not dementia progression. A person with dementia who develops a UTI may experience abdominal discomfort, appetite loss, increased confusion, and restlessness instead of the classic dysuria or fever symptoms that younger people report.

Once antibiotics begin, cognitive function typically improves within 1-2 days, suggesting that the confusion was a treatable acute symptom, not a permanent step toward cognitive decline. This reversibility is why doctors now screen: a simple urine test (checking white blood cell count, red blood cell count, and bacterial culture) can identify a treatable cause of acute confusion, improve quality of life immediately, and potentially prevent the cascade of complications that can follow untreated infection. However, the UTI example also reveals an important limitation: preventing delirium through prompt UTI detection is a worthwhile goal, but it’s distinct from preventing long-term dementia development. Someone who avoids a dozen UTI-related delirium episodes may still eventually develop dementia from other causes. The value of UTI screening lies in managing acute complications, not necessarily in altering the underlying dementia trajectory.

The Evidence Gap: What We Don’t Yet Know About Prevention

The critical caveat that runs through all infection-dementia research is this: we have strong evidence that infections are associated with increased dementia risk, but evidence remains inconclusive about whether screening for and treating infections prevents dementia from developing. This is not a trivial distinction. Epidemiological associations are tremendously useful for identifying which people are at risk and which risk factors warrant clinical attention, but they don’t automatically translate into effective interventions. It’s conceivable that infections are simply a marker of declining health rather than an independent driver of dementia—a person whose immune system can’t clear infections efficiently may also have underlying vascular disease, metabolic dysfunction, or genetic factors that directly cause cognitive decline.

Additionally, the timing question remains unresolved. Even if treating an infection reduces brain inflammation in the short term, we don’t know whether clearing an infection years after it originally occurred would prevent dementia in someone who has already accumulated neurological damage. The infection that occurred decades ago may have already set cognitive decline in motion. These uncertainties don’t negate the value of screening and treating infections—UTI detection improves acute outcomes, and clearing chronic infections like hepatitis C offers numerous health benefits—but they do require intellectual honesty: we’re screening and treating based on plausible biological mechanisms and epidemiological associations, not yet on proven dementia prevention efficacy.

The Evidence Gap: What We Don't Yet Know About Prevention

Why Is the Medical Community Shifting Its Approach Now?

The impetus for this shift comes largely from the 2024 Lancet Standing Commission report on dementia risk reduction, which identified infections as one of 14 modifiable factors accounting for approximately 45% of global dementia cases. This designation places infections alongside better-established risk factors like hypertension, diabetes, cognitive inactivity, and social isolation. The Commission’s report effectively said: if we’re serious about preventing dementia at the population level, we cannot ignore infections.

Simultaneously, the World Health Organization began updating its dementia prevention guidelines (starting in 2024) to incorporate new evidence on infections, signaling that a global consensus is forming around the importance of this connection. These institutional endorsements reflect not a sudden breakthrough discovery, but rather the accumulation of epidemiological evidence over the past decade making the infection-dementia link impossible to ignore. For individual clinicians, this means that screening for chronic infections is transitioning from an obscure research finding to a recognized component of dementia prevention.

What’s Next? The Future of Infection Screening in Dementia Prevention

The immediate future likely involves more targeted screening protocols and more sophisticated measurement of “infectious burden”—attempts to quantify not just whether someone had an infection, but how many infections they’ve accumulated, how severe they were, and how recently they occurred. Researchers are exploring whether cumulative burden measures predict dementia risk better than any single infection.

Longer-term, we may see clinical trials that explicitly test whether aggressive screening and treatment protocols alter dementia incidence, though such trials are complex and expensive. On a practical level, the medical community is increasingly adopting the principle that infections in people with existing cognitive impairment warrant thorough evaluation and treatment—not necessarily because treating the infection will prevent future dementia, but because it improves acute outcomes and quality of life.

Conclusion

Doctors are now screening for chronic infections as part of dementia prevention because solid epidemiological evidence links hospitalized infections—and several specific pathogens—to significantly elevated dementia risk. The mechanisms are plausible: infections trigger systemic inflammation that accelerates the brain pathology underlying cognitive decline. The real-world value is clearest in acute situations like UTI detection, where screening prevents delirium and improves immediate function.

However, intellectual honesty requires acknowledging that screening efficacy for long-term dementia prevention remains unproven; we have robust associations, not yet definitive proof that intervention changes dementia trajectories. As the World Health Organization updates its guidelines and the medical community integrates infections into dementia risk models, the message to patients and families is clear: infections warrant prompt attention and treatment, both for their acute effects and as part of a comprehensive approach to brain health. If you or a loved one experiences recurrent infections, discuss with your physician not just the immediate treatment, but the broader implications for long-term cognitive health. And if you notice acute confusion in someone with dementia, insist on infection screening—because in that moment, a simple urinary tract infection may be the culprit, and it’s treatable.